Novel imipridone combination therapies targeting oncohistone H3K27M mutant diffuse midline glioma (DMG)

被引：0
作者：
Borsuk, Robyn [1 ]
Zhou, Lanlan [2 ,3 ,4 ,5 ,6 ]
Lulla, Rishi [1 ]
El-Deiry, Wafik [2 ,3 ,4 ,5 ,6 ]
机构：
[1] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA
[2] Brown Univ, Joint Program Canc Biol, Providence, RI 02912 USA
[3] Lifespan Canc Inst, Providence, RI USA
[4] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA
[5] Lifespan, Dept Med, Hematol Oncol Div, Providence, RI USA
[6] Brown Univ, Providence, RI 02912 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-5407
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5407
引用
收藏
页数：2
相关论文
共 50 条
  • [41] METTL16 AS A THERAPEUTIC VULNERABILITY IN H3K27M MUTANT DMG CELLS
    Chilukuri, Akanksha
    Pomaville, Monica
    Halbert, Matthew
    He, Chaun
    Agnihotri, Sameer
    NEURO-ONCOLOGY, 2024, 26
  • [42] Diffuse Midline Glioma, H3 K27M-Mutant With Osseous Metastases At Diagnosis
    Fuller, Christine
    Lazow, Margot
    Johnson, Sheryl
    Vadivelu, Sudhakar
    Johnson, Neil
    Koch, Bernadette
    Leach, James
    O'Brien, William
    Breneman, John
    Trout, Andrew
    Fouladi, Maryam
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2020, 79 (06) : 669 - 669
  • [43] Four methods to analyze H3K27M mutation in diffuse midline gliomas
    Zhao, Huanying
    Fang, Xiao
    Xue, Bing
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (09)
  • [44] LSD1 DEGRADATION SYNERGIZES WITH HDAC INHIBITION IN PEDIATRIC H3K27M DIFFUSE MIDLINE GLIOMA
    Haase, Rebecca
    Groves, Andrew
    Mire, Hafsa
    Qi, Jun
    Filbin, Mariella
    NEURO-ONCOLOGY, 2023, 25
  • [45] Diffuse midline glioma-H3K27M mutant. A novel entity with a defining and specific IHC marker
    Agarwal, Prachi
    Aiyer, Hema Malini
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2021, 64 (02) : 351 - 353
  • [46] Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
    Peterson, Erik R.
    Sajjakulnukit, Peter
    Scott, Andrew J.
    Heaslip, Caleb
    Andren, Anthony
    Wilder-Romans, Kari
    Zhou, Weihua
    Palavalasa, Sravya
    Korimerla, Navyateja
    Lin, Angelica
    O'Brien, Alexandra
    Kothari, Ayesha
    Zhao, Zitong
    Zhang, Li
    Morgan, Meredith A.
    Venneti, Sriram
    Koschmann, Carl
    Jabado, Nada
    Lyssiotis, Costas A.
    Castro, Maria G.
    Wahl, Daniel R.
    CANCER & METABOLISM, 2024, 12 (01)
  • [47] Beyond Midline: Diffuse Hemispheric Glioma, H3 K27M-Mutant with Aggressive Behavior
    Valerio, Ediel
    Alves de Castro, Joao Victor
    Carraro, Dirce Maria
    Torrezan, Giovana Tardin
    Kulikowski, Leslie Domenici
    Costa, Felipe D'Almeida
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2022, 81 (05) : 381 - 383
  • [48] A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma
    Peng, Youheng
    Ren, Yanming
    Huang, Bowen
    Tang, Jun
    Jv, Yan
    Mao, Qing
    Liu, Yanhui
    Lei, Yinjie
    Zhang, Yuekang
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [49] Prolonged survival in a patient with a cervical spine H3K27M-mutant diffuse midline glioma
    Peters, Kelsey
    Pratt, Drew
    Koschmann, Carl
    Leung, Denise
    BMJ CASE REPORTS, 2019, 12 (10)
  • [50] Heterogeneous clinico-pathological features of diffuse midline glioma H3-K27M mutant
    Okamura, Yuma
    Kobayashi, Keiichi
    Saito, Kuniaki
    Shimada, Daisuke
    Suematsu, Shinya
    Chiba, Tomohiro
    Shibahara, Junji
    Shimizu, Saki
    Shiokawa, Yoshiaki
    Nagane, Motoo
    BRAIN PATHOLOGY, 2019, 29 : 147 - 147
12345